new era compounding tirzepatide added a new Zepbound From Eli Lilly and

BUT, please don't panic if you struggle to eat more than 1,000 calories in your first week - short term, this won't harm you

Developed by Danish pharmaceutical company Novo Nordisk, it targets multiple parts of the brain's appetite control system, reducing hunger and cravings for food

4 Exenatide has also been developed as a long-acting microsphere preparation suitable for once-weekly administration

Available at: Masson W, Lobo M, Nogueira JP, Barbagelata L, Touzas P, Fras JP

Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with type 2 diabetes

The cost of materials and production in China is significantly lower than in countries such as the US, UK, Germany, and Denmark